Physician profile
Patrick Maurice Thomae
NPI 1972898476
$724.50
in general payments reported to CMS, 2019-2025
12 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2023: $232 · 2024: $196 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $237.02 | 2023-2025 | |
| Intuitive Surgical, INC. | $128.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.12 | 2023 | |
| Merck Sharp & Dohme LLC | $64.70 | 2022-2024 | Gardasil 9, Capvaxive, Gardasil |
| Exact Sciences Corporation | $41.02 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $26.97 | 2024 | Wavewriter Alpha Prime 16 |
| Inspire Medical Systems, INC. | $20.95 | 2025 | Inspire |
| Sanofi Pasteur INC. | $20.74 | 2024 | |
| Medtronic, INC. | $18.93 | 2023 | Venaseal |
| Stryker Corporation | $15.84 | 2025 | Clottriever Bold Catheter |
| Corcept Therapeutics | $13.67 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $12.87 | 2023 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Thomae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.